Skip to main content

Day: May 3, 2021

Milestone Scientific Reports Preliminary Sales Results for Q1 2021; Revenue Increases 61% Over the Same Period Last Year

ROSELAND, N.J., May 03, 2021 (GLOBE NEWSWIRE) — Milestone Scientific Inc. (NYSE: MLSS), a leading developer of computerized drug delivery instruments that provide painless and precise injections, today provided a business update and announced preliminary financial results for the first quarter of 2021. Arjan Haverhals, President of Milestone Scientific and CEO of Wand Dental Inc., stated, “I am pleased to report that our revenue for the first quarter of 2021 increased more than 61% to $2.9 million versus $1.8 million for the same period last year. We also achieved a strong sequential increase in sales of 32% versus the fourth quarter of 2020. Importantly, we witnessed growth in both our domestic and international revenues. We attribute this improvement to the success of our new dental sales and marketing strategy. At the...

Continue reading

Latin America Fraud Detection and Prevention Market to Reach USD 2,945.3 Million by 2028; Increasing Incidence of Data Fraud to Stimulate Growth: Fortune Business Insights™

Key Companies Covered in Latin America fraud detection and prevention market are IBM Corporation (New York, United States), Uplexis (São Paulo, Brazil), Experian Information Solutions, Inc. (São Paulo, Brazil’s), Accenture PLC (Dublin, Ireland), Tata Communications (Maharashtra, India), Clearsale LLC (Florida, United States), Neoway (São Paulo, Brazil’s), Konduto (São Paulo, Brazil’s), Inovamind (São Paulo, Brazil’s), Único (São Paulo, Brazil’s), Cred Defense (Bebedouro, São Paulo), HS Prevent (São Paulo, Brazil’s) Pune, India, May 03, 2021 (GLOBE NEWSWIRE) — The Latin America fraud detection and prevention market size is expected to gain momentum by reaching USD 2,945.3 million by 2028 while exhibiting a CAGR of 20.0% between 2021 and 2028. Fortune Business Insights, in its latest report, titled “Latin America Fraud Detection...

Continue reading

AGTC Clinical Investigators Provide Encore Presentation of Data from the Company’s Ongoing XLRP and Achromatopsia Phase 1/2 Trials

-Company remains on track to present additional 12-month data from the XLRP and achromatopsia clinical trials in the second quarter of 2021- ALACHUA, Fla. and CAMBRIDGE, Mass., May 03, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC), a biotechnology company conducting human clinical trials of adeno-associated virus (AAV)-based gene therapies for the treatment of rare diseases, today announced an encore presentation of previously reported data from the Company’s ongoing clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM) at the Association for Research in Vision and Ophthalmology (ARVO) 2021 Virtual Annual Meeting. Paul Yang, MD, PhD, Assistant Professor at Casey Eye Institute, Oregon Health & Science University, will review the six-month data from the Phase 1/2 XLRP...

Continue reading

Dialyzer Market Size 2021 | To Steadily Rise to an Impressive USD 13,707.2 Million by 2026 with 4.9% CAGR

Top Players Covered in the Dialyzer Market Research Report are Fresenius Medical Care, Baxter International Inc., B. Braun Medical, Nipro Corporation, Nikkiso Co. Ltd, Asahi Kasei Corporation, JMS Co. Ltd, Toray Medical Co. Ltd, and other key market players Pune, India, May 03, 2021 (GLOBE NEWSWIRE) — The Global Dialyzer Market value to steadily rise to an impressive US$ 13,707.2 mn  by the end of 2026 from US$ 9344.7 mn in 2018, as chronic kidney diseases show an upward trend. Valuable insights into this market have been shared by Fortune Business Insights in its report, titled “Dialyzer Market Size, Share and Global Trend by Flux Type (High-flux, Low-Flux), By Usage Type (Disposable, Reusable), By End User (Dialysis Centers and Hospitals, Home Healthcare), and Geography Forecast till 2026”. The report provides a comprehensive...

Continue reading

Blockchain Foundry Deploys Syscoin LUX; Cutting-Edge Platform for NFTs and Compliant Payments

TORONTO, May 03, 2021 (GLOBE NEWSWIRE) — Blockchain Foundry Inc. (“BCF” or the “Company”) (CSE:BCFN), a leading North American blockchain development firm, is pleased to announce that, in conjunction with the Syscoin Foundation, it has successfully deployed Syscoin LUX, the latest version of the Syscoin blockchain. Syscoin is an open-source blockchain protocol that underpins many of BCF’s proprietary development efforts, and offers fast, highly scalable, and low-cost blockchain infrastructure for a wide variety of applications. Syscoin LUX introduces a range of new features which make Syscoin one of the best and most future-proof decentralized platforms for fungible and non-fungible tokens, payments, and non-custodial, rules-based compliance. Among other innovations, Syscoin LUX brings the following cutting-edge features to life:NFTs:...

Continue reading

Stem Cells Market Size 2021 | Is Expected to Showcase Considerable Growth by Reaching USD 27.65 Billion by 2028 While Exhibiting a CAGR of 12.8% between 2021 and 2028

Top Players Covered in the Stem Cells Market Research Report Are Thermo Fisher Scientific (Massachusetts, U.S), Merck KGaA (Germany, Europe), Mesoblast Ltd (Melbourne, Australia), STEMCELL Technologies Inc. (Vancouver, Canada), Promethera Biosciences SA (Belgium, Europe), Cynata Therapeutics (Victoria, Australia), R&D Systems, Inc. (Minnesota, U.S), AMSBIO (Abingdon, United Kingdom) and other key market players. Pune, India, May 03, 2021 (GLOBE NEWSWIRE) — The global stem cells market size is expected to showcase considerable growth by reaching USD 27.65 billion by 2028 while exhibiting a CAGR of 12.8% between 2021 and 2028. This information is published by Fortune Business Insights in its report, titled “Stem Cells Industry, 2021-2028.” The report further observes that the market stood at USD 10.56 billion in 2020. Factors...

Continue reading

Resonant to Report First Quarter 2021 Financial Results on Wednesday, May 12th at 1:30 p.m. Pacific Time

AUSTIN, Texas, May 03, 2021 (GLOBE NEWSWIRE) — Resonant Inc. (NASDAQ: RESN), a provider of radio frequency (RF) filter solutions developed on a robust intellectual property platform, designed to connect People and Things, will release financial results for the first quarter ended March 31st, 2021 after market close on Wednesday, May 12th, 2021. Management will host a conference call on Wednesday, May 12th, 2021, at 1:30 p.m. Pacific standard time (4:30 p.m. Eastern standard time) to discuss Resonant’s first quarter 2021 financial results. The call will conclude with Q&A from participants. To participate, please use the following information: Q1 2021 Conference Call and WebcastDate: Wednesday, May 12th, 2021Time: 1:30 p.m. Pacific standard time (4:30 p.m. Eastern standard time)U.S. Dial-In: 1-877-423-9813International Dial-In:...

Continue reading

Presentation of DKT Holdings and TDC’s Q1 2021 results – Correction of date

 TDC will conduct a conference call for investors and analysts on May 6, 2021 at 14.30 CET to present the Q1 2021 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call. The investor and analyst conference will be available in Microsoft Teams at: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1M2I2ZDQtNzdhNC00OWQzLTg2NTgtYzcyZGQxZTdhYzhh%40thread.v2/0?context=%7b%22Tid%22%3a%22e8dcf6e6-3acc-4af9-9cb2-77f688cb688b%22%2c%22Oid%22%3a%22e3bc77b8-3126-4e3f-b136-3297ef0a91d3%22%7d Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 256 316 081#The conference call will refer to a slide deck that will be available from May 6, 2021 at approx. 10.00 CET on the link: https://tdcgroup.com/en/investor-relations Please mute your microphone before and during the presentation....

Continue reading

Exagen Announces New Campaign and Initiatives for Lupus Awareness Month

SAN DIEGO, May 03, 2021 (GLOBE NEWSWIRE) — Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced, in recognition of Lupus Awareness Month, the launch of awareness initiatives and educational tools highlighting the importance of an accurate and timely diagnosis and patient monitoring for Systemic Lupus Erythematosus (SLE). Emphasizing the patient journey from overlapping symptoms to diagnosis and monitoring, Exagen has launched a new campaign called “Know With AVISE”. Each week in the month of May, Exagen will focus on a step in the patient’s journey with lupus to bring attention to the signs and symptoms of lupus and the issues and challenges people face. In collaboration with the Lupus Foundation of America, Exagen will shed light on the difficulties of diagnosing lupus accurately, as well...

Continue reading

Presentation of DKT Holdings and TDC’s Q1 2021 results

TDC will conduct a conference call for investors and analysts on March 6, 2021 at 14.30 CET to present the Q1 2021 results. Lasse Pilgaard, Chief Financial Officer, will comment on the results and answer questions during the conference call. The investor and analyst conference will be available in Microsoft Teams at: https://teams.microsoft.com/l/meetup-join/19%3ameeting_YWM1M2I2ZDQtNzdhNC00OWQzLTg2NTgtYzcyZGQxZTdhYzhh%40thread.v2/0?context=%7b%22Tid%22%3a%22e8dcf6e6-3acc-4af9-9cb2-77f688cb688b%22%2c%22Oid%22%3a%22e3bc77b8-3126-4e3f-b136-3297ef0a91d3%22%7d Dial in to Microsoft Teams is: +45 32 72 51 67 – Code: 256 316 081#The conference call will refer to a slide deck that will be available from March 6, 2021 at approx. 10.00 CET on the link: https://tdcgroup.com/en/investor-relations Please mute your microphone before and during the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.